182 related articles for article (PubMed ID: 8242578)
1. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
[TBL] [Abstract][Full Text] [Related]
2. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer.
Neal CE; Meis LC
Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356).
Wynant GE; Murphy GP; Horoszewicz JS; Neal CE; Collier BD; Mitchell E; Purnell G; Tyson I; Heal A; Abdel-Nabi H
Prostate; 1991; 18(3):229-41. PubMed ID: 2020619
[TBL] [Abstract][Full Text] [Related]
4. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
[TBL] [Abstract][Full Text] [Related]
5. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
Abdel-Nabi HH; Doerr RJ
Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in ovarian and prostate cancer.
Neal CE; Swenson LC; Fanning J; Texter JH
Semin Nucl Med; 1993 Apr; 23(2):114-26. PubMed ID: 8511599
[TBL] [Abstract][Full Text] [Related]
8. Improved detection of hepatic lesions using MoAb B72.3 and a modified 111In labelling technique in patients with recurrent colon cancer.
Vijayakumar V; Blend MJ; Johnson DK; Seevers RH; Schnobrich KE; Bekerman C
Nucl Med Commun; 1993 Aug; 14(8):658-66. PubMed ID: 8371891
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of In-111 satumomab pendetide immunoscintigraphy. An aid to visual interpretation of images in patients with suspected carcinomatosis.
Neal CE; Johnson DL; Cornwell VL; Markwell S
Clin Nucl Med; 1996 Aug; 21(8):638-42. PubMed ID: 8853918
[TBL] [Abstract][Full Text] [Related]
10. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
[TBL] [Abstract][Full Text] [Related]
11. In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results.
Abdel-Nabi H; Doerr RJ; Chan HW; Balu D; Schmelter RF; Maguire RT
Radiology; 1990 Apr; 175(1):163-71. PubMed ID: 2315476
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy in primary colorectal cancer.
Ryan JW
Cancer; 1993 Jun; 71(12 Suppl):4217-24. PubMed ID: 8508383
[TBL] [Abstract][Full Text] [Related]
13. Immunoscintigraphy with 111In-satumomab pendetide in patients with colorectal adenocarcinoma: performance and impact on clinical management.
Corman ML; Galandiuk S; Block GE; Prager ED; Weiner GJ; Kahn D; Abdel-Nabi H; Mitchell EP; Pascucci VL; Maroli AN
Dis Colon Rectum; 1994 Feb; 37(2):129-37. PubMed ID: 8306832
[TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.
Manyak MJ; Hinkle GH; Olsen JO; Chiaccherini RP; Partin AW; Piantadosi S; Burgers JK; Texter JH; Neal CE; Libertino JA; Wright GL; Maguire RT
Urology; 1999 Dec; 54(6):1058-63. PubMed ID: 10604708
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.
Sakahara H; Onodera H; Shirato M; Yao Z; Ohshio G; Kobayashi H; Hosono M; Yano S; Nakada H; Imamura M
Cancer Immunol Immunother; 1995 Sep; 41(3):157-61. PubMed ID: 7553684
[TBL] [Abstract][Full Text] [Related]
17. Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody.
Davidson BR; Young H; Waddington WA; Babich J; Clarke GA; Short MD; Boulos PB; Styles J; Dean C; Ell PJ
Cancer; 1992 Feb; 69(3):620-5. PubMed ID: 1730114
[TBL] [Abstract][Full Text] [Related]
18. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
[TBL] [Abstract][Full Text] [Related]
19. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
[TBL] [Abstract][Full Text] [Related]
20. Indium-111 satumomab pendetide: the first FDA-approved monoclonal antibody for tumor imaging.
Bohdiewicz PJ
J Nucl Med Technol; 1998 Sep; 26(3):155-63; quiz 170-1. PubMed ID: 9755434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
